IdeS, an IgG-degrading enzyme of Streptococcus pyogenes
AssigneeHansa Medical Research AB
InventorsUlrich Von Pawel-Rammingen, Bjorn Johansson, Lars Björck
Life of this patent
Estimating the term…
Abstract
A polypeptide isolated from S. pyogenes is described, having IgG cysteine protease activity. The protease is designated IdeS, Immunoglobulin G-degrading enzyme of S. pyogenes. A polypeptide comprises SEQ ID NO: 1 and variants and fragments thereof having IgG cysteine protease activity or the ability to generate an immune response against S. pyogenes in an individual. Polynucleotides encoding these polypeptides and the polypeptides may be used in generating an immune response in an individual. IdeS protease inhibitors may be used in the treatment of S. pyogenes infection.
Claims5
A method of generating Fc or Fab fragments of IgG comprising:
- (i) contacting IgG with:
- a) polypeptide having the sequence of SEQ ID NO:
- 1, or
- b) a polypeptide having the sequence of SEQ ID NO:
- 1 except for 1, 2 or 3 conservative substitutions,
- wherein said polypeptide (a) and said polypeptide (b) have a cysteine residue at the position corresponding to position 65 of SEQ ID NO:1, position 65 of SEQ ID NO:1 corresponding to position 94 of SEQ ID NO:2,
- wherein IgG is contacted with said polypeptide (a) or said polypeptide (b) under conditions that permit the IgG specific cysteine protease activity of said polypeptide (a) or said polypeptide (b);
- (ii) thereby generating said fragments of IgG;
- and
- (iii) isolating the fragments of IgG obtained, or analysing the starting materials or reaction products to determine whether the desired product is present.
A method for detecting IgG in a sample, comprising:
- (i) contacting said sample with a substantially purified polypeptide, said polypeptide:
- a) having the sequence of SEQ ID NO:
- 1, or
- b) having the sequence of SEQ ID NO:
- 1 except for 1, 2 or 3 conservative substitutions
- wherein said polypeptide (a) and said polypeptide (b) have a cysteine residue at the position corresponding to position 65 of SEQ ID NO:1, position 65 of SEQ ID NO:1 corresponding to position 94 of SEQ ID NO:2,
- wherein IgG is contacted with said polypeptide (a) or said polypeptide (b) under conditions that permit the IgG specific cysteine protease activity of said polypeptide (a) or said polypeptide (b);
- and
- (ii) monitoring for the presence of IgG specific cleavage fragments;
- wherein the presence of the specific cleavage fragments is indicative of IgG in the sample.
Dependencies are inferred from the claim text.